Ron,
Please see the message from ONCOSTAT using this link:
http://agoracom.com/ir/Mannkind/forums/discussion/topics/535740-today-s-trading/messages/1692292#message
The type 2 trial is a double blind study, but I believe that the company may not be excluded from being able to interpret. At least they are not mentioned in the blind listing.